244 related articles for article (PubMed ID: 31625920)
21. Efficacy and safety of ingenol mebutate gel in field treatment of actinic keratosis on full face, balding scalp, or approximately 250 cm
Hanke CW; Albrecht L; Skov T; Larsson T; Østerdal ML; Spelman L
J Am Acad Dermatol; 2020 Mar; 82(3):642-650. PubMed ID: 31374304
[TBL] [Abstract][Full Text] [Related]
22. Real-life efficacy and safety of ingenol mebutate for the treatment of actinic keratosis of the face and scalp: A single arm retrospective study.
Ricci F; Tambone S; Neri L; Fania L; Piccioni A; Guerriero C; Fargnoli MC; Peris K
J Dermatolog Treat; 2016 Nov; 27(6):525-530. PubMed ID: 27043050
[TBL] [Abstract][Full Text] [Related]
23. Ingenol mebutate gel for actinic keratosis.
Lebwohl M; Swanson N; Anderson LL; Melgaard A; Xu Z; Berman B
N Engl J Med; 2012 Mar; 366(11):1010-9. PubMed ID: 22417254
[TBL] [Abstract][Full Text] [Related]
24. Ingenol mebutate in the treatment of actinic keratoses: clearance rate and adverse effects.
Saraiva MIR; Portocarrero LKL; Vieira MAHB; Swiczar BCC; Westin AT
An Bras Dermatol; 2018; 93(4):529-534. PubMed ID: 30066759
[TBL] [Abstract][Full Text] [Related]
25. Survey of Patient Satisfaction With Ingenol Mebutate Gel Treatment for Actinic Keratosis From a Community Dermatology Practice.
Schaefer D
Skinmed; 2016; 14(4):259-265. PubMed ID: 27784514
[TBL] [Abstract][Full Text] [Related]
26. Cost-effectiveness of Ingenol Mebutate Gel for the Treatment of Actinic Keratosis in Greece.
Athanasakis K; Boubouchairopoulou N; Tarantilis F; Tsiantou V; Kontodimas S; Kyriopoulos J
Clin Ther; 2017 May; 39(5):993-1002. PubMed ID: 28449867
[TBL] [Abstract][Full Text] [Related]
27. Assessment of Efficacy and Irritation of Ingenol Mebutate Gel 0.015% Used With or Without Dimethicone Lotion for Treatment of Actinic Keratosis on the Face.
Jim On SC; Hashim PW; Nia JK; Lebwohl MG
J Drugs Dermatol; 2017 May; 16(5):432-436. PubMed ID: 28628678
[TBL] [Abstract][Full Text] [Related]
28. Efficacy and safety of ingenol mebutate 0.015% gel 3 weeks after cryosurgery of actinic keratosis: 11-week results.
Berman B; Goldenberg G; Hanke CW; Tyring SK; Werschler WP; Knudsen KM; Goncalves J; Larsson T; Skov T; Swanson N
J Drugs Dermatol; 2014 Feb; 13(2):154-60. PubMed ID: 24509965
[TBL] [Abstract][Full Text] [Related]
29. Safety and Efficacy of Escalating Doses of Ingenol Mebutate for Field Treatment of Actinic Keratosis on the Full Face, Full Balding Scalp, or Chest.
Hanke CW; Berman B; Swanson N; Pariser DM; Weiss JS; Bukhalo M; Skov T; Villumsen J; Siegel D
J Drugs Dermatol; 2017 May; 16(5):438-444. PubMed ID: 28628679
[TBL] [Abstract][Full Text] [Related]
30. Topical Ingenol Mebutate: A New Treatment Modality for Multiple Actinic Keratoses and Field Cancerization.
Kostovic K; Gulin SJ; Mokos ZB; Ceovic R
Anticancer Agents Med Chem; 2017; 17(10):1304-1311. PubMed ID: 28270072
[TBL] [Abstract][Full Text] [Related]
31. Pharmacokinetic and pharmacodynamic evaluation of ingenol mebutate for the treatment of actinic keratosis.
Stockfleth E; Bastian M
Expert Opin Drug Metab Toxicol; 2018 Sep; 14(9):911-918. PubMed ID: 30074409
[TBL] [Abstract][Full Text] [Related]
32. Ingenol mebutate: a promising treatment for actinic keratoses and nonmelanoma skin cancers.
Gupta AK; Paquet M
J Cutan Med Surg; 2013; 17(3):173-9. PubMed ID: 23673300
[TBL] [Abstract][Full Text] [Related]
33. Treatment of facial actinic keratoses with aminolevulinic acid photodynamic therapy (ALA-PDT) or ingenol mebutate 0.015% gel with and without prior treatment with ALA-PDT.
Berman B; Nestor MS; Newburger J; Park H; Swenson N
J Drugs Dermatol; 2014 Nov; 13(11):1353-6. PubMed ID: 25607702
[TBL] [Abstract][Full Text] [Related]
34. A dose-finding trial with a novel ingenol derivative (ingenol disoxate: LEO 43204) for field treatment of actinic keratosis on full face or 250 cm
Bourcier M; Stein Gold L; Guenther L; Andreassen CM; Selmer J; Goldenberg G
J Dermatolog Treat; 2017 Nov; 28(7):652-658. PubMed ID: 28264612
[TBL] [Abstract][Full Text] [Related]
35. A seamless phase I/II dose-finding trial assessing ingenol disoxate (LEO 43204) for field treatment of actinic keratosis on the scalp.
Weiss J; Ulrich M; Bukhalo M; Østerdal ML; Bang B; Hanke CW
Br J Dermatol; 2017 Jun; 176(6):1456-1464. PubMed ID: 28078678
[TBL] [Abstract][Full Text] [Related]
36. Ingenol mebutate: a new option for actinic keratosis treatment.
Gras J
Drugs Today (Barc); 2013 Jan; 49(1):15-22. PubMed ID: 23362492
[TBL] [Abstract][Full Text] [Related]
37. Patient-reported outcomes of topical therapies in actinic keratosis: A systematic review.
Grada A; Feldman SR; Bragazzi NL; Damiani G
Dermatol Ther; 2021 Mar; 34(2):e14833. PubMed ID: 33527673
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of the tolerability and safety of a 0.015% ingenol mebutate gel compared to 5% 5-fluorouracil cream for the treatment of facial actinic keratosis: a prospective randomized trial.
Samorano LP; Torezan LA; Sanches JA
J Eur Acad Dermatol Venereol; 2015 Sep; 29(9):1822-7. PubMed ID: 25727104
[TBL] [Abstract][Full Text] [Related]
39. A randomized, phase IIa exploratory trial to assess the safety and preliminary efficacy of LEO 43204 in patients with actinic keratosis.
Sinnya S; Tan JM; Prow TW; Primiero C; McEniery E; Selmer J; Østerdal ML; Soyer HP
Br J Dermatol; 2016 Feb; 174(2):305-11. PubMed ID: 26499175
[TBL] [Abstract][Full Text] [Related]
40. Regression Analysis of Local Skin Reactions to Predict Clearance of Actinic Keratosis on the Face in Patients Treated With Ingenol Mebutate Gel: Experience from Randomized Controlled Trials.
Jim On S; Knudsen KM; Skov T; Lebwohl M
J Drugs Dermatol; 2017 Feb; 16(2):112-114. PubMed ID: 28300852
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
